What is the peri‑operative management of a patient who sustained a road‑traffic accident with a left femur fracture and has a history of ischemic heart disease treated with percutaneous coronary intervention, currently taking aspirin and clopidogrel?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Perioperative Management of Femur Fracture with IHD Post-PCI on Dual Antiplatelet Therapy

In this trauma patient requiring urgent femur fracture surgery while on aspirin and clopidogrel after PCI, continue aspirin perioperatively and stop clopidogrel 5 days before surgery if the stent is >6-12 months old; if the stent is <6-12 months old, maintain both agents and proceed to surgery immediately given the life-threatening nature of the femur fracture. 12

Critical Initial Assessment

Immediately determine:

  • Timing of PCI and stent type (bare metal vs drug-eluting)
  • Time since stent placement (most critical factor)
  • Bleeding risk of femur surgery (intermediate-to-major hemorrhagic risk)
  • Risk factors for stent thrombosis (diabetes, multiple stents, bifurcation lesions, incomplete revascularization, low ejection fraction) 2

Management Algorithm Based on Stent Timing

If Stent Placed <30 Days (BMS) or <6-12 Months (DES):

This is the highest-risk scenario for stent thrombosis. 12

  • Continue BOTH aspirin and clopidogrel through surgery 22
  • Do NOT delay surgery - femur fractures require urgent fixation (ideally <24 hours) to reduce mortality and morbidity 34
  • Accept increased bleeding risk as the alternative (stent thrombosis) carries 45% mortality 1
  • Have tranexamic acid and platelet concentrates available 3
  • Restart clopidogrel immediately postoperatively with 300mg loading dose 22

If Stent Placed >6-12 Months (DES) or >30 Days (BMS):

This represents moderate thrombotic risk. 22

  • Continue aspirin perioperatively (this is the preferred strategy) 222
  • Stop clopidogrel 5 days before surgery (compromise between platelet half-life and thrombosis risk) 22
  • Restart clopidogrel within 24-48 hours postoperatively with 300mg loading dose 22
  • Surgery should still occur urgently, ideally within 24 hours of stopping clopidogrel 3

Multidisciplinary Team Meeting

Before proceeding, convene an urgent discussion including: 22

  • Cardiologist (assess stent thrombosis risk)
  • Orthopedic surgeon (assess bleeding risk and surgical urgency)
  • Anesthesiologist (anesthetic plan, neuraxial vs general)
  • Hematologist if available

Document the agreed plan clearly in the medical record. 2

Anesthetic Considerations

  • Neuraxial anesthesia is SAFE with aspirin alone 3
  • Neuraxial anesthesia is CONTRAINDICATED with dual antiplatelet therapy (risk of spinal hematoma)
  • Use general anesthesia if continuing both agents 3

Critical Pitfalls to Avoid

DO NOT delay surgery beyond 24 hours - the 2011 study showed patients on clopidogrel with delayed surgery (mean 8 days) had 25.9% medical complications and 14.8% mortality, compared to 18% complications and 11% mortality in matched controls operated at 2.3 days 4. The mortality difference, while not statistically significant in that small study, demonstrates the danger of prolonged delays.

DO NOT use bridging therapy with LMWH or unfractionated heparin - this increases bleeding risk without proven benefit in preventing stent thrombosis, and heparin rebound can paradoxically increase thrombotic risk 123

DO NOT stop aspirin - the 2014 ACC/AHA guidelines emphasize that aspirin should be continued in patients with previous coronary stenting when cardiac event risk outweighs bleeding risk 1, and the French Task Force specifically recommends maintaining aspirin regardless of when the stent was placed 22

Postoperative Management

  • Resume clopidogrel as soon as hemostasis is secure (typically 24-48 hours) 23
  • Consider 300mg loading dose to rapidly restore platelet inhibition 22
  • Continue aspirin without interruption
  • Monitor for both bleeding complications and cardiac events
  • Maintain VTE prophylaxis with mechanical measures initially

Evidence Strength and Nuances

The 2014 ACC/AHA guideline 1 is the most authoritative source but acknowledges limited prospective data. The POISE-2 trial showed aspirin increased bleeding without reducing cardiac events, but excluded patients within 1 year of DES placement - precisely the highest-risk population in this case. The French Task Force recommendations 2222222, while older (2006), provide the most specific algorithmic approach to this exact clinical scenario and remain widely cited.

Recent evidence 3 from 2024 supports early surgery without discontinuing antiplatelet therapy in femur fractures, with antifibrinolytic therapy and platelet transfusion reserved for significant bleeding.

The fundamental principle: in trauma requiring urgent surgery, the risk of delaying surgery typically exceeds the risk of bleeding, especially given modern hemostatic techniques.

Related Questions

In an 86-year-old female with a right intertrochanteric femur fracture who is taking clopidogrel 150 mg daily and aspirin 75 mg daily, how should her antiplatelet therapy be managed perioperatively?
What are the cardiac risks associated with cataract surgery and what pre‑operative cardiac assessment and peri‑operative management (including anticoagulation handling) are recommended for patients with coronary artery disease, heart failure, significant valvular disease, or arrhythmias?
What is the recommended duration of anticoagulation after femur fracture repair?
What is the appropriate aspirin dose (mg) for deep vein thrombosis prophylaxis before an ultrasound?
What are the differences between a proximal femur (hip) fracture and a femoral shaft fracture, and how should EMS assess and manage each injury?
How should I manage a patient with isolated hypoxemia (pO2 51 mm Hg), anemia (hemoglobin 9.5 g/dL), hyperglycemia (glucose 14.6 mmol/L), and mild hyponatremia (sodium 130 mmol/L)?
Why should Miniheparin 5,000 U subcutaneously twice daily be used in a patient with an estimated creatinine clearance of 13 mL/min?
In a patient with liver cirrhosis and a serum sodium of 125 mmol/L, should the hyponatremia be corrected?
For vitamin B12 deficiency neuropathy, should cyanocobalamin be administered intramuscularly or intravenously?
Is an Escherichia coli isolate that is resistant to cefuroxime but susceptible to ceftriaxone and cefotaxime likely to be susceptible to cefixime?
If she has low hemoglobin, how should prophylactic unfractionated heparin be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.